Therapeutics: NF-κB interacting lncRNA (NKILA)

Cancer

INDICATION: Breast cancer

Studies in cell culture, patient samples and mice suggest NKILA could

Read the full 133 word article

How to gain access

Continue reading with a
two-week free trial.